These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 10949326)

  • 1. Progress and problems in achieving the United States national target for completion of antituberculosis treatment.
    Chin DP; Cummings KC; Sciortino S; Snyder DC; Johnson LF; Westenhouse JL; Royce SE
    Int J Tuberc Lung Dis; 2000 Aug; 4(8):744-51. PubMed ID: 10949326
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Completion of tuberculosis therapy for patients reported in the United States in 1993.
    Bloch AB; Cauthen GM; Simone PM; Kelly GD; Dansbury KG; Castro KG
    Int J Tuberc Lung Dis; 1999 Apr; 3(4):273-80. PubMed ID: 10206496
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Directly observed therapy (DOT) is not the entire answer: an operational cohort analysis.
    Mangura B; Napolitano E; Passannante M; Sarrel M; McDonald R; Galanowsky K; Reichman L
    Int J Tuberc Lung Dis; 2002 Aug; 6(8):654-61. PubMed ID: 12150475
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improved adherence and less toxicity with rifampin vs isoniazid for treatment of latent tuberculosis: a retrospective study.
    Page KR; Sifakis F; Montes de Oca R; Cronin WA; Doherty MC; Federline L; Bur S; Walsh T; Karney W; Milman J; Baruch N; Adelakun A; Dorman SE
    Arch Intern Med; 2006 Sep; 166(17):1863-70. PubMed ID: 17000943
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of Mycobacterium bovis infected tuberculosis patients: San Diego County, California, United States, 1994-2003.
    LoBue PA; Moser KS
    Int J Tuberc Lung Dis; 2005 Mar; 9(3):333-8. PubMed ID: 15786900
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Characteristics and treatment outcomes of INH-resistant or RFP-resistant tuberculosis].
    Saito W; Nagayama N; Miyamoto M; Hara H; Suzuki J; Masuda K; Baba M; Tamura A; Nagai H; Akagawa S; Kawabe Y; Machida K; Kurashima A; Yotsumoto H
    Kekkaku; 2003 Oct; 78(10):611-7. PubMed ID: 14621568
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Incidence of and factors for non-compliance to antituberculous treatment].
    Cáceres Fde M; Orozco LC
    Biomedica; 2007 Dec; 27(4):498-504. PubMed ID: 18320117
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mortality and failure among tuberculosis patients who did not complete treatment in Vietnam: a cohort study.
    Vree M; Huong NT; Duong BD; Sy DN; Van le N; Co NV; Cobelens FG; Borgdorff MW
    BMC Public Health; 2007 Jul; 7():134. PubMed ID: 17605770
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Isoniazid-monoresistant tuberculosis in the United States, 1993 to 2003.
    Hoopes AJ; Kammerer JS; Harrington TA; Ijaz K; Armstrong LR
    Arch Intern Med; 2008 Oct; 168(18):1984-92. PubMed ID: 18852399
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Incidence of TB in inmates with latent TB infection: 5-year follow-up.
    White MC; Tulsky JP; Menendez E; Goldenson J; Kawamura LM
    Am J Prev Med; 2005 Nov; 29(4):295-301. PubMed ID: 16242592
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long term follow up of HIV-infected patients with tuberculosis treated with 6-month intermittent short course chemotherapy.
    Swaminathan S; Deivanayagam CN; Rajasekaran S; Venkatesan P; Padmapriyadarsini C; Menon PA; Ponnuraja C; Dilip M
    Natl Med J India; 2008; 21(1):3-8. PubMed ID: 18472696
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A retrospective evaluation of completion rates, total cost, and adverse effects for treatment of latent tuberculosis infection in a public health clinic in central massachusetts.
    Young H; Wessolossky M; Ellis J; Kaminski M; Daly JS
    Clin Infect Dis; 2009 Aug; 49(3):424-7. PubMed ID: 19548835
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Isoniazid- and rifampin-resistant tuberculosis in San Diego County, California, United States, 1993-2002.
    LoBue PA; Moser KS
    Int J Tuberc Lung Dis; 2005 May; 9(5):501-6. PubMed ID: 15875920
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Factors associated with compliance among tuberculosis patients in Thailand.
    Lertmaharit S; Kamol-Ratankul P; Sawert H; Jittimanee S; Wangmanee S
    J Med Assoc Thai; 2005 Sep; 88 Suppl 4():S149-56. PubMed ID: 16623020
    [TBL] [Abstract][Full Text] [Related]  

  • 15. DOT and timely treatment completion among Asian-born immigrant tuberculosis patients.
    Liu SY; Li JH; Schluger NW
    Int J Tuberc Lung Dis; 2005 Aug; 9(8):884-9. PubMed ID: 16104635
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Excess mortality and risk factors for mortality among a cohort of TB patients from rural south India.
    Kolappan C; Subramani R; Kumaraswami V; Santha T; Narayanan PR
    Int J Tuberc Lung Dis; 2008 Jan; 12(1):81-6. PubMed ID: 18173882
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Factors associated with tuberculosis treatment default and completion at the Effia-Nkwanta Regional Hospital in Ghana.
    Dodor EA; Afenyadu GY
    Trans R Soc Trop Med Hyg; 2005 Nov; 99(11):827-32. PubMed ID: 16102791
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk factors for defaulting from tuberculosis treatment: a prospective cohort study of 301 cases in the Gambia.
    Hill PC; Stevens W; Hill S; Bah J; Donkor SA; Jallow A; Lienhardt C
    Int J Tuberc Lung Dis; 2005 Dec; 9(12):1349-54. PubMed ID: 16466057
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predictors of failure to complete treatment for latent tuberculosis infection.
    Parsyan AE; Saukkonen J; Barry MA; Sharnprapai S; Horsburgh CR
    J Infect; 2007 Mar; 54(3):262-6. PubMed ID: 16772095
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.